ETFs

ProShares Ultra Nasdaq Biotechnology

BIB:NMQ:USD

ProShares Ultra Nasdaq Biotechnology

Actions
  • Price (USD)57.02
  • Today's Change1.48 / 2.66%
  • Shares traded1.27m
  • 1 Year change46.54%
Data delayed at least 15 minutes, as of Jun 22 2017.
More ▼

Trailing total returns

Daily
5 years3 years1 year6 months3 months1 month
ProShares Ultra Nasdaq Biotechnology+30.85%+4.15%-1.47%+6.94%-8.12%-8.01%
Trading--Leveraged Equity+18.63%+20.57%+15.53%+3.54%+3.07%+9.42%
NASDAQ Biotechnology TR USD------------
Fund quartile2nd3rd4th3rd3rd4th
Funds in category101105105105110110
As of May 31 2017.

Traling returns analysis

3M

The chart shows how frequently the fund's 3M return is positive or negative. Each bar is an observation period (the fund's return over the past 3M, at month's end).

Intra-day ETF pricing data provided by
© Thomson Reuters Click for restrictions
The performance data shown in tables and graphs on this page is calculated in USD of the fund/index/average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.
All managed funds data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2017
All Rights reserved
© 2017 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.